0810010067/J591; A Randomized Phase II Trial of 177-Lu Radio-labeled Monoclonal Antibody HuJ591 (177-Lu-J591) with Ketoconazole in Patients with High-Risk Castrate Biochemically Relapsed Prostate Cancer after Local Therapy

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Prostate Cancer
  • Age: Between 18 - 100 Years
  • Gender: Male

Inclusion Criteria
Histologically or cytologically confirmed adenocarcinoma of the prostate previously treated with surgery and/or radiotherapy
Biochemical progression (rising PSA) after medical or surgical castration
High risk of systemic progression
Exclusion Criteria
Use of red blood cell or platelet transfusions within 4 weeks of treatment
Use of hematopoietic growth factors within 4 weeks of treatment
Active serious infection
History of deep vein thrombosis and/or pulmonary embolus within 3 months of study entry
Known history of HIV.
Currently active other malignancy other than non-melanoma skin cancer.

Recruitment Status


Contact the research team to learn more about this study.

Fields marked with asterisk (*) are required

Please verify that you are not a bot.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Volunteer Sign up

Volunteer Registry

Create your profile and be matched to research opportunities

Register Now!

Contact Us

If you need help finding a study or have any questions, please contact us at inhealth@iu.edu or by phone at (888) 264-0005.